Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,376,498
-$2,133,318 QoQ
Shares Held
360,443
-0.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#66
of 712 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CSM Advisors, LLC holds $167,508,675 across 11 Drug Manufacturers - General names. SNY ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
219,688 | $55,794,161 | |
| 2 | ABBV |
AbbVie Inc.
|
143,403 | $36,085,930 | |
| 3 | LLY |
ELI LILLY & Co
|
27,478 | $32,957,940 | |
| 4 | PFE |
Pfizer Inc
|
889,436 | $21,417,618 | |
| 5 | SNY |
Sanofi
This page
|
360,443 | $15,376,498 | |
| 6 | NVS |
Novartis AG
|
11,160 | $1,748,995 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,162 | $1,305,817 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,282 | $1,172,687 |
All Filings in SNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,376,498 | 360,443 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,509,816 | 363,425 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,353,393 | 420,004 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $18,244,404 | 386,534 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||